Strategic Insight: Carbon Health’s Boom, Bust, and Bankruptcy

Summary

Carbon Health surged during the pandemic, scaling from a few clinics to over 125 locations across 13 states by leveraging COVID‑19 testing sites and telehealth, and raising more than $600 million in venture capital, including a $350 million Series D at a $3.3 billion valuation. The company’s aggressive growth plan targeted 1,500 clinics by 2025, positioning itself as the largest primary‑care network in the U.S., and attracted a $100 million strategic investment from CVS Health. However, the rapid expansion exposed operational and financial strains that ultimately led to a collapse and bankruptcy, illustrating the risks of hyper‑growth in health‑tech. The analysis highlights how pandemic‑driven hype can mask underlying business fundamentals.